Urgent Product Recall: Accu-Chek Solo cannula assembly and pump holder and Accu-Chek Solo supply kit 22 December 2022 The Therapeutic Goods Administration (TGA) and Roche Diabetes Care have issued an urgent medical device recall for Accu-Chek Solo cannula assembly and pump holder, and the supply kit. Roche Diabetes Care has identified that insulin leakage has occurred in a small number of cases with the Accu-Chek Solo cannula assembly and pump holder (6mm and 9mm, NDSS codes 851 and 852) and the Accu-Chek Solo supply kit (6mm and 9mm). Discontinue use of these products immediately. The insulin leakage may not be noticed straight away, which could lead to an under-delivery of insulin. The possible consequences could range from no clinical impact to severe hypoglycaemia (dangerously low blood glucose levels) or diabetic ketoacidosis (DKA). Please contact Roche Diabetes customer care on 1800 251 816 for information on how to return the impacted stock and receive the replacement. The complete recall notice from the TGA is available here.
Media releases 4 September 2024 New Australian Diabetes Clinical Trials Network will change lives Image: (L-R) Keren Pointon, Dr Lisa Hayes, Dr Anish Menon, Prof Elif Ekinci, Justine Cain, Susan Kozij, Prof David O’Neal,... Continue Reading
Blog 6 August 2024 Medications for respiratory tract infections: The good, the unreliable, and the old fashioned Your respiratory tract is made up of an upper section (mouth, throat, nose, sinuses and vocal cords) and a lower... Continue Reading
News 2 August 2024 Wegovy to be available in Australia A new weight loss medicine, Wegovy, will be available in Australia from early August 2024. Pharmaceutical company Novo Nordisk made... Continue Reading